Proteomics in mechanistic toxicology: History, concepts, achievements, caveats, and potential

Proteomics

Volumn 15, Issue 5-6, 2015, Pages 1051-1074

  Rabilloud, Thierry ^a,b,c   Lescuyer, Pierre ^d,e  

^a CNRS   (France)

^b UNIV GRENOBLE ALPES   (France)

^c CEA GRENOBLE   (France)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cell biology; Toxicology

Indexed keywords

DRUG; INDUSTRIAL CHEMICAL; METAL; METALLOID; NANOFIBER; NANOPARTICLE; NATURAL PRODUCT; PROTEIN; PROTEOME; TOXIC SUBSTANCE;

COVALENT BOND; DRUG EFFECT; DRUG RESPONSE; HUMAN; ISOTOPE LABELING; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; TOXICOLOGY; VALIDATION STUDY; ANIMAL; CYTOLOGY; MOUSE; NANOTECHNOLOGY; RAT;

MAMMALIA;

ANIMALS; CELL BIOLOGY; HUMANS; MICE; NANOTECHNOLOGY; PROTEOMICS; RATS; TOXICOLOGY;

EID: 84924598514     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400288     Document Type: Review

References (237)

1. Johnston, D., Oppermann, H., Jackson, J., Levinson, W., Induction of 4 proteins in chick-embryo cells by sodium arsenite. J. Biol. Chem. 1980, 255, 6975-6980.
2. Kim, Y. J., Shuman, J., Sette, M., Przybyla, A., Arsenate induces stress proteins in cultured rat myoblasts. J. Cell Biol. 1983, 96, 393-400.
3. Anderson, N. L., Gemmell, M. A., Protein-pattern changes and morphological effects due to methionine starvation or treatment with 5-azacytidine of the phorbol-ester-sensitive cell lines HL-60, CCL-119, and U-937. Clin. Chem. 1984, 30, 1956-1964.
4. Anderson, N. L., Swanson, M., Giere, F. A., Tollaksen, S. et al., Effects of Aroclor-1254 on proteins of mouse liver-application of two-dimensional electrophoretic protein mapping. Electrophoresis 1986, 7, 44-48.
5. Anderson, N. L., Giere, F. A., Nance, S. L., Gemmell, M. A. et al., Effects of toxic agents at the protein level-quantitative measurement of 213 mouse-liver proteins following xenobiotic treatment. Fund. Appl. Toxicol. 1987, 8, 39-50.
6. Witzmann, F. A., Bale, S. S., London, S. A., Determination of perfluoro-normal-decanoic acid toxicity invitro and invivo via two-dimensional polyacrylamide-gel electrophoresis. Electrophoresis 1988, 9, 641-641.
7. Franke, W. W., Winter, S., Grund, C., Schmid, E. et al., Isolation and characterization of desmosome-associated tonofilaments from rat intestinal brush border. J. Cell Biol. 1981, 90, 116-127.
8. Vlasuk, G. P., Ryan, D. E., Thomas, P. E., Levin, W., Walz, F. G., Polypeptide patterns of hepatic microsomes from long-evans rats treated with different xenobiotics. Biochemistry 1982, 21, 6288-6292.
9. Witzmann, F. A., Parker, D. N., Jarnot, B. M., Induction of enoyl-coa hydratase by Ld(50) exposure to perfluorocarboxylic acids detected by 2-dimensional electrophoresis. Toxicol. Lett. 1994, 71, 271-277.
10. Steiner, S., Aicher, L., Raymackers, J., Meheus, L. et al., Cyclosporine A decreases the protein level of the calcium-binding protein calbindin-D 28kDa in rat kidney. Biochem. Pharmacol. 1996, 51, 253-258.
11. Aicher, L., Wahl, D., Arce, A., Grenet, O., Steiner, S., New insights into cyclosporine A nephrotoxicity by proteome analysis. Electrophoresis 1998, 19, 1998-2003.
12. Dowling, V. A., Sheehan, D., Proteomics as a route to identification of toxicity targets in environmental toxicology. Proteomics 2006, 6, 5597-5604.
13. Steiner, S., Anderson, N. L., Expression profiling in toxicology-potentials and limitations. Toxicol. Lett. 2000, 112, 467-471.
14. Burchiel, S. W., Knall, C. M., Davis, J. W., Paules, R. S. et al., Analysis of genetic and epigenetic mechanisms of toxicity: potential roles of toxicogenomics and proteomics in toxicology. Toxicol. Sci. 2001, 59, 193-195.
15. Moller, A., Soldan, M., Volker, U., Maser, E., Two-dimensional gel electrophoresis: a powerful method to elucidate cellular responses to toxic compounds. Toxicology 2001, 160, 129-138.
16. Walgren, J. L., Thompson, D. C., Application of proteomic technologies in the drug development process. Toxicol. Lett. 2004, 149, 377-385.
17. Wetmore, B. A., Merrick, B. A., Toxicoproteomics: proteomics applied to toxicology and pathology. Toxicol. Pathol. 2004, 32, 619-642.
18. Collins, B. C., Clarke, A., Kitteringham, N. R., Gallagher, W. M., Pennington, S. R., Use of proteomics for the discovery of early markers of drug toxicity. Expert Opin. Drug Metab. Toxicol. 2007, 3, 689-704.
19. Merrick, B. A., Witzmann, F. A., The role of toxicoproteomics in assessing organ specific toxicity. EXS 2009, 99, 367-400.
20. Gao, Y., Holland, R. D., Yu, L. R., Quantitative proteomics for drug toxicity. Brief Funct. Genomic Proteomic 2009, 8, 158-166.
21. George, J., Singh, R., Mahmood, Z., Shukla, Y., Toxicoproteomics: new paradigms in toxicology research. Toxicol. Mech. Methods 2010, 20, 415-423.
22. Amacher, D. E., The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity. Toxicol. Appl. Pharmacol. 2010, 245, 134-142.
23. Schmitz-Spanke, S., Rettenmeier, A. W., Protein expression profiling in chemical carcinogenesis: a proteomic-based approach. Proteomics 2011, 11, 644-656.
24. Raida, M., Drug target deconvolution by chemical proteomics. Curr. Opin. Chem. Biol. 2011, 15, 570-575.
25. George, J., Shukla, Y., Pesticides and cancer: insights into toxicoproteomic-based findings. J. Proteomics 2011, 74, 2713-2722.
26. Van Summeren, A., Renes, J., van Delft, J. H. M., Kleinjans, J. C. S., Mariman, E. C. M., Proteomics in the search for mechanisms and biomarkers of drug-induced hepatotoxicity. Toxicol. In Vitro 2012, 26, 373-385.
27. Hess, S., The emerging field of chemo- and pharmacoproteomics. Proteomics Clin. Appl. 2013, 7, 171-180.
28. Verma, N., Pink, M., Rettenmeier, A. W., Schmitz-Spanke, S., Review on proteomic analyses of benzo[a]pyrene toxicity. Proteomics 2012, 12, 1731-1755.
29. Aardema, M. J., MacGregor, J. T., Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Mutat. Res. 2002, 499, 13-25.
30. Merrick, B. A., Madenspacher, J. H., Complementary gene and protein expression studies and integrative approaches in toxicogenomics. Toxicol. Appl. Pharmacol. 2005, 207, 189-194.
31. Harrill, A. H., Rusyn, I., Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity. Expert Opin. Drug Metab. Toxicol. 2008, 4, 1379-1389.
32. Lazarou, J., Pomeranz, B. H., Corey, P. N., Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J. Am. Med. Assoc. 1998, 279, 1200-1205.
33. Fountoulakis, M., Berndt, P., Boelsterli, U. A., Crameri, F. et al., Two-dimensional database of mouse liver proteins: changes in hepatic protein levels following treatment with acetaminophen or its nontoxic regioisomer 3-acetamidophenol. Electrophoresis 2000, 21, 2148-2161.
34. Guo, C., Gasparian, A. V., Zhuang, Z., Bosykh, D. A. et al., 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappa B and p53 pathways. Oncogene 2009, 28, 1151-1161.
35. Cheung, M. T. W., Ramalingam, R., Lau, K. K. K., Chiang, M. W. L. et al., Cell type-dependent effects of andrographolide on human cancer cell lines. Life Sci. 2012, 91, 751-760.
36. Gamberi, T., Massai, L., Magherini, F., Landini, I. et al., Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy. J. Proteomics 2014, 103, 103-120.
37. Cecconi, D., Astner, H., Donadelli, M., Palmieri, M. et al., Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2 '-deoxycytidine. Electrophoresis 2003, 24, 4291-4303.
38. Tian, E. B., Tang, H. P., Xu, R. H., Liu, C. D. et al., Azacytidine induces necrosis of multiple myeloma cells through oxidative stress. Proteome Sci. 2013, 11, 24. doi:10.1186/1477-5956-11-24.
39. Uttenweiler-Joseph, S., Bouyssie, D., Calligaris, D., Lutz, P. G. et al., Quantitative proteomic analysis to decipher the differential apoptotic response of bortezomib-treated APL cells before and after retinoic acid differentiation reveals involvement of protein toxicity mechanisms. Proteomics 2013, 13, 37-47.
40. Chavez, J. D., Hoopmann, M. R., Weisbrod, C. R., Takara, K., Bruce, J. E., Quantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cells. PLoS One 2011, 6, e19892.
41. Cho, Y. E., Singh, T. S. K., Lee, H. C., Moon, P. G. et al., In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach. Mol. Cell. Proteomics 2012, 11, M11.010884.
42. Chappell, N. P., Teng, P. N., Hood, B. L., Wang, G. et al., Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancer. J. Proteome Res. 2012, 11, 4605-4614.
43. Lamoureux, F., Mestre, E., Essig, M., Sauvage, F. L. et al., Quantitative proteomic analysis of cyclosporine-induced toxicity in a human kidney cell line and comparison with tacrolimus. J. Proteomics 2011, 75, 677-694.
44. Gratia, S., Kay, L., Michelland, S., Seve, M. et al., Cardiac phosphoproteome reveals cell signaling events involved in doxorubicin cardiotoxicity. J. Proteomics 2012, 75, 4705-4716.
45. Hong, D., Chen, H. X., Yu, H. Q., Wang, C. et al., Quantitative proteomic analysis of dexamethasone-induced effects on osteoblast differentiation, proliferation, and apoptosis in MC3T3-E1 cells using SILAC. Osteoporosis Int. 2011, 22, 2175-2186.
46. Dukes, A. A., Van Laar, V. S., Cascio, M., Hastings, T. G., Changes in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamine. J. Neurochem. 2008, 106, 333-346.
47. Marin-Vicente, C., Lyutvinskiy, Y., Fuertes, P. R., Zubarev, R. A., Visa, N., The effects of 5-fluorouracil on the proteome of colon cancer cells. J. Proteome Res. 2013, 12, 1969-1979.
48. Cecconi, D., Mion, S., Astner, H., Domenici, E. et al., Proteomic analysis of rat cortical neurons after fluoxetine treatment. Brain Res. 2007, 1135, 41-51.
49. Friry-Santini, C., Rouquie, D., Kennel, P., Tinwell, H. et al., Correlation between protein accumulation profiles and conventional toxicological findings using a model antiandrogenic compound, flutamide. Toxicol. Sci. 2007, 97, 81-93.
50. Steiner, S., Gatlin, C. L., Lennon, J. J., McGrath, A. M. et al., Cholesterol biosynthesis regulation and protein changes in rat liver following treatment with fluvastatin. Toxicol. Lett. 2001, 120, 369-377.
51. Wang, C., Zhou, J. R., Wang, S. W., Ye, M. L. et al., Shotgun approach based comparative proteomic analysis of levo-tetrahydropalmatine-induced apoptosis in hepatocytes. Toxicol. Lett. 2010, 194, 8-15.
52. Steiner, S., Gatlin, C. L., Lennon, J. J., McGrath, A. M. et al., Proteomics to display lovastatin-induced protein and pathway regulation in rat liver. Electrophoresis 2000, 21, 2129-2137.
53. Groebe, K., Hayess, K., Klemm-Manns, M., Schwall, G. et al., Unexpected common mechanistic pathways for embryotoxicity of warfarin and lovastatin. Reprod. Toxicol. 2010, 30, 121-130.
54. Park, S., Lee, J., Proteomic analysis to identify early molecular targets of pregabalin in C6 glial cells. Cell Biol. Int. 2010, 34, 27-33.
55. Zhang, L., Chang, M., Li, H. J., Hou, S. et al., Proteomic changes of PC12 cells treated with proteasomal inhibitor PSI. Brain Res. 2007, 1153, 196-203.
56. Cho, Y. E., Moon, P. G., Lee, J. E., Singh, T. S. et al., Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity. Proteomics 2013, 13, 1257-1275.
57. Koncarevic, S., Urig, S., Steiner, K., Rahlfs, S. et al., Differential genomic and proteomic profiling of glioblastoma cells exposed to terpyridineplatinum(II) complexes. Free Radic. Biol.Med. 2009, 46, 1096-1108.
58. Cho, Y. E., Kim, S. H., Baek, M. C., Proteome profiling of tolbutamide-treated rat primary hepatocytes using nano LC-MS/MS and label-free protein quantitation. Electrophoresis 2012, 33, 2806-2817.
59. Maniratanachote, R., Minami, K., Katoh, M., Nakajima, M., Yokoi, T., Chaperone proteins involved in troglitazone-induced toxicity in human hepatoma cell lines. Toxicol. Sci. 2005, 83, 293-302.
60. Lee, Y. H., Bin Goh, W. W., Ng, C. K., Raida, M. et al., Integrative toxicoproteomics implicates impaired mitochondrial glutathione import as an off-target effect of troglitazone. J. Proteome Res. 2013, 12, 2933-2945.
61. Baek, S. M., Ahn, J. S., Noh, H. S., Park, J. et al., Proteomic analysis in NSAIDs-treated primary cardiomyocytes. J. Proteomics 2010, 73, 721-732.
62. Matheis, K. A., Com, E., Gautier, J. C., Guerreiro, N. et al., Cross-study and cross-omics comparisons of three nephrotoxic compounds reveal mechanistic insights and new candidate biomarkers. Toxicol. Appl. Pharmacol. 2011, 252, 112-122.
63. Man, W. J., White, I. R., Bryant, D., Bugelski, P. et al., Protein expression analysis of drug-mediated hepatotoxicity in the Sprague-Dawley rat. Proteomics 2002, 2, 1577-1585.
64. Thome-Kromer, B., Bonk, I., Klatt, M., Nebrich, G. et al., Toward the identification of liver toxicity markers: a proteome study in human cell culture and rats. Proteomics 2003, 3, 1835-1862.
65. Van Summeren, A., Renes, J., Bouwman, F. G., Noben, J. P. et al., Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells. Toxicol. Sci. 2011, 120, 109-122.
66. Chen, J. Y., Hu, R. Y., Chou, H. C., Quercetin-induced cardioprotection against doxorubicin cytotoxicity. J. Biomed. Sci. 2013, 20, 95. doi:10.1186/1423-0127-20-95.
67. Diaz-Chavez, J., Fonseca-Sanchez, M. A., Arechaga-Ocampo, E., Flores-Perez, A. et al., Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy. PLoS One 2013, 8, e64378.
68. Lincet, H., Guevel, B., Pineau, C., Allouche, S. et al., Comparative 2D-DIGE proteomic analysis of ovarian carcinoma cells: toward a reorientation of biosynthesis pathways associated with acquired platinum resistance. J. Proteomics 2012, 75, 1157-1169.
69. Murphy, L., Henry, M., Meleady, P., Clynes, M., Keenan, J., Proteomic investigation of taxol and taxotere resistance and invasiveness in a squamous lung carcinoma cell line. Biochim. Biophys. Acta 2008, 1784, 1184-1191.
70. Urbani, A., Poland, J., Bernardini, S., Bellincampi, L. et al., A proteomic investigation into etoposide chemo-resistance of neuroblastoma cell lines. Proteomics 2005, 5, 796-804.
71. Qi, J., Liu, N., Zhou, Y., Tan, Y. H. et al., Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis. Biochem. Biophys. Res. Commun. 2006, 349, 303-309.
72. Di Michele, M., Della Corte, A., Cicchillitti, L., Del Boccio, P. et al., A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. Biochim. Biophys. Acta 2009, 1794, 225-236.
73. Peng, X. C., Gong, F. M., Xie, G., Zhao, Y. W. et al., A proteomic investigation into adriamycin chemo-resistance of human leukemia K562 cells. Mol. Cell. Biochem. 2011, 351, 233-241.
74. Brown, K. J., Fenselau, C., Investigation of doxorubicin resistance in MCF-7 breast cancer cells using shot-gun comparative proteomics with proteolytic O-18 labeling. J. Proteome Res. 2004, 3, 455-462.
75. Sinha, P., Poland, J., Kohl, S., Schnolzer, M. et al., Study of the development of chemoresistance in melanoma cell lines using proteome analysis. Electrophoresis 2003, 24, 2386-2404.
76. Castagna, A., Antonioli, P., Astner, H., Hamdan, M. et al., A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. Proteomics 2004, 4, 3246-3267.
77. Hutter, G., Sinha, P., Proteomics for studying cancer cells and the development of chemoresistance. Proteomics 2001, 1, 1233-1248.
78. Sinha, P., Hutter, G., Kottgen, E., Dietel, M. et al., Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells. J. Biochem. Biophys. Methods 1998, 37, 105-116.
79. Sinha, P., Hutter, G., Kottgen, E., Dietel, M. et al., Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis 1999, 20, 2952-2960.
80. Kellmann, R., Schaffner, C. A. M., Gronset, T. A., Satake, M. et al., Proteomic response of human neuroblastoma cells to azaspiracid-1. J. Proteomics 2009, 72, 695-707.
81. Deganuto, M., Cesaratto, L., Bellarosa, C., Calligaris, R. et al., A proteomic approach to the bilirubin-induced toxicity in neuronal cells reveals a protective function of DJ-1 protein. Proteomics 2010, 10, 1645-1657.
82. Fung, K. Y. C., Brierley, G. V., Henderson, S., Hoffmann, P. et al., Butyrate-induced apoptosis in HCT116 colorectal cancer cells includes induction of a cell stress response. J. Proteome Res. 2011, 10, 1860-1869.
83. Feng, L., Zhang, D., Fan, C., Ma, C. et al., ER stress-mediated apoptosis induced by celastrol in cancer cells and important role of glycogen synthase kinase-3 beta in the signal network. Cell Death Dis. 2013, 4, e715.
84. Hansen, J., Palmfeldt, J., Vang, S., Corydon, T. J. et al., Quantitative proteomics reveals cellular targets of celastrol. Plos One 2011, 6, e26634.
85. Nogueira da Costa, A., Mijal, R. S., Keen, J. N., Findlay, J. B., Wild, C. P., Proteomic analysis of the effects of the immunomodulatory mycotoxin deoxynivalenol. Proteomics 2011, 11, 1903-1914.
86. Qiu, J., Gao, H. Q., Liang, Y., Yu, H., Zhou, R. H., Comparative proteomics analysis reveals role of heat shock protein 60 in digoxin-induced toxicity in human endothelial cells. Biochim. Biophys. Acta 2008, 1784, 1857-1864.
87. Wang, Z. Y., Kang, H., Ji, L. L., Yang, Y. Q. et al., Proteomic characterization of the possible molecular targets of pyrrolizidine alkaloid isoline-induced hepatotoxicity. Environ. Toxicol. Pharmacol. 2012, 34, 608-617.
88. Sala, G. L., Bellocci, M., Rossini, G. P., The cytotoxic pathway triggered by palytoxin involves a change in the cellular pool of stress response proteins. Chem. Res. Toxicol. 2009, 22, 2009-2016.
89. Heo, S. H., Oh, J. H., Park, H. J., Kwon, M. S. et al., Toxicoproteomic analysis of phalloidin-induced cholestasis in mouse liver. Mol. Cell. Toxicol. 2010, 6, 87-95.
90. Siu, F. M., Ma, D. L., Cheung, Y. W., Lok, C. N. et al., Proteomic and transcriptomic study on the action of a cytotoxic saponin (Polyphyllin D): induction of endoplasmic reticulum stress and mitochondria-mediated apoptotic pathways. Proteomics 2008, 8, 3105-3117.
91. Vanamala, J., Radhakrishnan, S., Reddivari, L., Bhat, V. B., Ptitsyn, A., Resveratrol suppresses human colon cancer cell proliferation and induces apoptosis via targeting the pentose phosphate and the talin-FAK signaling pathways-a proteomic approach. Proteome Sci. 2011, 9, 49. doi:10.1186/1477-5956-9-49.
92. Short, D. M., Heron, I. D., Birse-Archbold, J. L. A., Kerr, L. E. et al., Apoptosis induced by staurosporine alters chaperone and endoplasmic reticulum proteins: identification by quantitative proteornics. Proteomics 2007, 7, 3085-3096.
93. Pan, T. L., Wang, P. W., Hung, Y. C., Huang, C. H., Rau, K. M., Proteomic analysis reveals tanshinone IIA enhances apoptosis of advanced cervix carcinoma CaSki cells through mitochondria intrinsic and endoplasmic reticulum stress pathways. Proteomics 2013, 13, 3411-3423.
94. Foldi, I., Toth, A. M., Szabo, Z., Mozes, E. et al., Proteome-wide study of endoplasmic reticulum stress induced by thapsigargin in N2a neuroblastoma cells. Neurochem. Int. 2013, 62, 58-69.
95. Xu, Y., Chiu, L. F., He, Q. Y., Chen, F., Tubeimoside-1 exerts cytotoxicity in HeLa cells through mitochondrial dysfunction and endoplasmic reticulum stress pathways. J. Proteome Res. 2009, 8, 1585-1593.
96. Liu, Q., Zhao, X. P., Lu, X. Y., Fan, X. H., Wang, Y., Proteomic study on usnic-acid-induced hepatotoxicity in rats. J. Agric. Food Chem. 2012, 60, 7312-7317.
97. Wang, P., Bouwman, F. G., Mariman, E. C. M., Generally detected proteins in comparative proteomics-a matter of cellular stress response? Proteomics 2009, 9, 2955-2966.
98. Sarkar, P., Hayes, B. E., Proteomic profiling of rat lung epithelial cells induced by acrolein. Life Sci. 2009, 85, 188-195.
99. Murugesan, K., Baumann, S., Wissenbach, D. K., Kliemt, S. et al., Subtoxic and toxic concentrations of benzene and toluene induce Nrf2-mediated antioxidative stress response and affect the central carbon metabolism in lung epithelial cells A549. Proteomics 2013, 13, 3211-3221.
100. Oh, S., Im, H., Oh, E., Lee, J. et al., Effects of benzo(a)pyrene on protein expression in Jurkat T-cells. Proteomics 2004, 4, 3514-3526.
101. Verma, N., Pink, M., Rettenmeier, A. W., Schmitz-Spanke, S., Benzo[a]pyrene-mediated toxicity in primary pig bladder epithelial cells: a proteomic approach. J. Proteomics 2013, 85, 53-64.
102. Betancourt, A. M., Wang, J., Jenkins, S., Mobley, J. et al., Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol a and genistein. J. Nutr. 2012, 142, 1382S-S1388.
103. Lee, D. Y., Lee, S. S., Joo, W. A., Lee, E. J., Kim, C. W., Analysis of differentially regulated proteins in TM4 cells treated with bisphenol A. Biosci. Biotechnol.Biochem. 2004, 68, 1201-1208.
104. Ahlborn, G. J., Delker, D. A., Roop, B. C., Geter, D. R. et al., Early alterations in protein and gene expression in rat kidney following bromate exposure. Food Chem. Toxicol. 2009, 47, 1154-1160.
105. Pang, C. Y., Chiu, S. C., Harn, H. J., Zhai, W. J. et al., Proteomic-based identification of multiple pathways underlying n-butylidenephthalide-induced apoptosis in LNCaP human prostate cancer cells. Food Chem. Toxicol. 2013, 59, 281-288.
106. Fountoulakis, M., de Vera, M. C., Crameri, F., Boess, F. et al., Modulation of gene and protein expression by carbon tetrachloride in the rat liver. Toxicol. Appl. Pharmacol. 2002, 183, 71-80.
107. Morbt, N., Tomm, J., Feltens, R., Mogel, I. et al., Chlorinated benzenes cause concomitantly oxidative stress and induction of apoptotic markers in lung epithelial cells (A549) at nonacute toxic concentrations. J. Proteome Res. 2011, 10, 363-378.
108. Lin, P. P., Yang, M. H., Liao, P. C., Wu, H. Y. et al., Proteomic analysis of proteins associated with tt-DDE induced toxicity in BEAS-2B cells. Biochem. Biophys. Res. Commun. 2008, 376, 519-524.
109. Harris, W., Sachana, M., Flaskos, J., Hargreaves, A. J., Proteomic analysis of differentiating neuroblastoma cells treated with sub-lethal neurite inhibitory concentrations of diazinon: identification of novel biomarkers of effect. Toxicol. Appl. Pharmacol. 2009, 240, 159-165.
110. Shen, H., Liao, K., Zhang, W., Wu, H. et al., Differential expression of peroxiredoxin 6, annexin A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1 in testis of rat fetuses after maternal exposure to di-n-butyl phthalate. Reprod. Toxicol. 2013, 39, 76-84.
111. Zhang, W., Shen, H., Ma, L., Shen, B. X. et al., Differential expression of peroxiredoxin 6 in fetal rat testis following in utero exposure to di(nbuty1) phthalate. Toxicology 2007, 240, 86-95.
112. Spiess, P. C., Morin, D., Williams, C. R., Buckpittl, A. R., Protein thiol oxidation in murine airway epithelial cells in response to naphthalene or diethyl maleate. Am. J. Resp. Cell Mol. Biol. 2010, 43, 316-325.
113. Pelletier, G., Masson, S., Wang, Y. L., Wade, M. G. et al., Proteomic investigation of 1, 6-dimethoxyhexane testicular toxicity. Environ. Toxicol. Pharmacol. 2007, 24, 129-133.
114. Oh, J. H., Heo, S. H., Park, H. J., Choi, M. S. et al., Genomic and proteomic analyses of 1, 3-dinitrobenzene-induced testicular toxicity in Sprague-Dawley rats. Reprod. Toxicol. 2014, 43, 45-55.
115. Kim, J. H., In, Y. J., Kim, W. K., Bae, K. H. et al., Differential signatures of protein glycosylation and phosphorylation in human Chang liver cells induced by TCDD treatment. Toxicol. Lett. 2008, 178, 20-28.
116. Sarioglu, H., Brandner, S., Jacobsen, C., Meindl, T. et al., Quantitative analysis of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-induced proteome alterations in 5L rat hepatoma cells using isotope-coded protein labels. Proteomics 2006, 6, 2407-2421.
117. Uchida, T., Ohashi, Y., Morikawa, E., Tsugita, A., Takeda, K., Proteome analysis of the effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on murine testicular Leydig and Sertoli cells. J. Health Sci. 2001, 47, 136-144.
118. Drake, M. G., Witzmann, F. A., Hyde, J., Witten, M. L., JP-8 jet fuel exposure alters protein expression in the lung. Toxicology 2003, 191, 199-210.
119. George, J., Prasad, S., Mahmood, Z., Shukla, Y., Studies on glyphosate-induced carcinogenicity in mouse skin: a proteomic approach. J. Proteomics 2010, 73, 951-964.
120. Kleno, T. G., Leonardsen, L. R., Kjeldal, H. O., Laursen, S. M. et al., Mechanisms of hydrazine toxicity in rat liver investigated by proteomics and multivariate data analysis. Proteomics 2004, 4, 868-880.
121. Isoda, H., Talorete, T. P. N., Han, J., Nakamura, K., Expressions of galectin-3, glutathione S-transferase A2 and peroxiredoxin-1 by nonylphenol-incubated Caco-2 cells and reduction in transepithelial electrical resistance by nonylphenol. Toxicol. In Vitro 2006, 20, 63-70.
122. Huang, Q. Y., Zhang, J., Martin, F. L., Peng, S. Y. et al., Perfluorooctanoic acid induces apoptosis through the p53-dependent mitochondrial pathway in human hepatic cells: a proteomic study. Toxicol. Lett. 2013, 223, 211-220.
123. Kodavanti, P. R. S., Osorio, C., Royland, J. E., Ramabhadran, R., Alzate, O., Aroclor 1254, a developmental neurotoxicant, alters energy metabolism- and intracellular signaling-associated protein networks in rat cerebellum and hippocampus. Toxicol. Appl. Pharmacol. 2011, 256, 290-299.
124. Campagna, R., Brunelli, L., Airoldi, L., Fanelli, R. et al., Cerebellum proteomics addressing the cognitive deficit of rats perinatally exposed to the food-relevant polychlorinated biphenyl 138. Toxicol. Sci. 2011, 123, 170-179.
125. Brunelli, L., Llansola, M., Felipo, V., Campagna, R. et al., Insight into the neuroproteomics effects of the food-contaminant non-dioxin like polychlorinated biphenyls. J. Proteomics 2012, 75, 2417-2430.
126. Low, T. Y., Leow, C. K., Salto-Tellez, M., Chung, M. C., A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers. Proteomics 2004, 4, 3960-3974.
127. Hooven, L. A., Baird, W. M., Proteomic analysis of MCF-7 cells treated with benzo[a]pyrene, dibenzo[a, l]pyrene, coal tar extract, and diesel exhaust extract. Toxicology 2008, 249, 1-10.
128. Yuan, F. Q., Lu, J., You, P., Yang, Z. M. et al., Proteomic profiling of expression of proteasomal subunits from livers of mice treated with diethylnitrosamine. Proteomics 2013, 13, 389-397.
129. de Graauw, M., Le Devedec, S., Tijdens, I., Smeets, M. B. et al., Proteomic analysis of alternative protein tyrosine phosphorylation in 1, 2-dichlorovinyl-cysteine-induced cytotoxicity in primary cultured rat renal proximal tubular cells. J. Pharmacol. Exp. Ther. 2007, 322, 89-100.
130. Luque-Garcia, J. L., Cabezas-Sanchez, P., Camara, C., Proteomics as a tool for examining the toxicity of heavy metals. Trends Anal. Chem. 2011, 30, 703-716.
131. Ge, F., Lu, X. P., Zeng, H. L., He, Q. Y. et al., Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. J. Proteome Res. 2009, 8, 3006-3019.
132. Xiong, L., Wang, Y., Quantitative proteomic analysis reveals the perturbation of multiple cellular pathways in HL-60 cells induced by arsenite treatment. J. Proteome Res. 2010, 9, 1129-1137.
133. Berglund, S. R., Santana, A. R., Li, D., Rice, R. H. et al., Proteomic analysis of low dose arsenic and ionizing radiation exposure on keratinocytes. Proteomics 2009, 9, 1925-1938.
134. Kita, K., Suzuki, T., Ochi, T., Down-regulation of glutaminase C in human hepatocarcinoma cell by diphenylarsinic acid, a degradation product of chemical warfare agents. Toxicol. Appl. Pharmacol. 2007, 220, 262-270.
135. Thongboonkerd, V., Semangoen, T., Sinchaikul, S., Chen, S. T., Proteomic analysis of calcium oxalate monohydrate crystal-induced cytotoxicity in distal renal tubular cells. J. Proteome Res. 2008, 7, 4689-4700.
136. Singhto, N., Sintiprungrat, K., Sinchaikul, S., Chen, S. T., Thongboonkerd, V., Proteome changes in human monocytes upon interaction with calcium oxalate monohydrate crystals. J. Proteome Res. 2010, 9, 3980-3988.
137. Singhto, N., Sintiprungrat, K., Thongboonkerd, V., Alterations in macrophage cellular proteome induced by calcium oxalate crystals: the association of HSP90 and F-actin is important for phagosome formation. J. Proteome Res. 2013, 12, 3561-3572.
138. Rousselet, E., Martelli, A., Chevallet, M., Diemer, H. et al., Zinc adaptation and resistance to cadmium toxicity in mammalian cells: molecular insight by proteomic analysis. Proteomics 2008, 8, 2244-2255.
139. Choi, K. M., Youn, H. S., Lee, M. Y., Genomic and proteomic profiling of the cadmium cytotoxic response in human lung epithelial cells. Mol. Cell. Toxicol. 2009, 5, 198-206.
140. Zhang, Q. H., Zou, P., Zhan, H. C., Zhang, M. J. et al., Dihydrolipoamide dehydrogenase and cAMP are associated with cadmium-mediated Leydig cell damage. Toxicol. Lett. 2011, 205, 183-189.
141. Pan, T. L., Wang, P. W., Chen, C. C., Fang, J. Y., Sintupisut, N., Functional proteomics reveals hepatotoxicity and the molecular mechanisms of different forms of chromium delivered by skin administration. Proteomics 2012, 12, 477-489.
142. Lei, T., He, Q. Y., Cai, Z., Zhou, Y. et al., Proteomic analysis of chromium cytotoxicity in cultured rat lung epithelial cells. Proteomics 2008, 8, 2420-2429.
143. Pan, T. L., Wang, P. W., Huang, C. M., Chen, C. C., Fang, J. Y., Elucidation of the percutaneous absorption of chromium compounds by functional proteomics. Proteomics 2009, 9, 5120-5131.
144. Raghunathan, V. K., Grant, M. H., Ellis, E. M., Changes in protein expression associated with chronic in vitro exposure of hexavalent chromium to osteoblasts and monocytes: a proteomic approach. J. Biomed. Mater. Res. Part A 2010, 92A, 615-625.
145. Zhang, Q., Zhang, L., Xiao, X., Su, Z. et al., Heavy metals chromium and neodymium reduced phosphorylation level of heat shock protein 27 in human keratinocytes. Toxicol. In Vitro 2010, 24, 1098-1104.
146. Han, D. M., Choi, M. R., Jung, K. H., Lee, H. T. et al., Proteomic analysis of the copper ion-induced stress response in a human embryonic carcinoma cell line. Int. J. Toxicol. 2012, 31, 397-406.
147. Petrak, J., Myslivcova, D., Man, P., Cmejla, R. et al., Proteomic analysis of iron overload in human hepatoma cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, G1059-G1066.
148. Cuello, S., Ramos, S., Madrid, Y., Luque-Garcia, J. L., Camara, C., Differential protein expression of hepatic cells associated with MeHg exposure: deepening into the molecular mechanisms of toxicity. Anal. Bioanal. Chem. 2012, 404, 315-324.
149. Zhang, S. R., Fu, J. L., Zhou, Z. C., Changes in the brain mitochondrial proteome of male Sprague-Dawley rats treated with manganese chloride. Toxicol. Appl. Pharmacol. 2005, 202, 13-17.
150. Acevedo, F., Serra, M. A., Ermolli, M., Clerici, L., Vesterberg, O., Nickel-induced proteins in human HaCaT keratinocytes: annexin II and phosphoglycerate kinase. Toxicology 2001, 159, 33-41.
151. Pan, T. L., Wang, P. W., Al-Suwayeh, S. A., Chen, C. C., Fang, J. Y., Skin toxicology of lead species evaluated by their permeability and proteomic profiles: a comparison of organic and inorganic lead. Toxicol. Lett. 2010, 197, 19-28.
152. Prat, O., Berenguer, F., Malard, V., Tavan, E. et al., Transcriptomic and proteomic responses of human renal HEK293 cells to uranium toxicity. Proteomics 2005, 5, 297-306.
153. Malard, V., Prat, O., Darrouzet, E., Berenguer, F. et al., Proteomic analysis of the response of human lung cells to uranium. Proteomics 2005, 5, 4568-4580.
154. Kindermann, B., Doring, F., Fuchs, D., Pfaffl, M. W., Daniel, H., Effects of increased cellular zinc levels on gene and protein expression in HT-29 cells. Biometals 2005, 18, 243-253.
155. Tsai, Y. Y., Huang, Y. H., Chao, Y. L., Hu, K. Y. et al., Identification of the nanogold particle-induced endoplasmic reticulum stress by omic techniques and systems biology analysis. Acs Nano 2011, 5, 9354-9369.
156. Blaber, S. P., Hill, C. J., Webster, R. A., Say, J. M. et al., Effect of labeling with iron oxide particles or nanodiamonds on the functionality of adipose-derived mesenchymal stem cells. Plos One 2013, 8, e52997.
157. Teeguarden, J. G., Webb-Robertson, B. J., Waters, K. M., Murray, A. R. et al., Comparative proteomics and pulmonary toxicity of instilled single-walled carbon nanotubes, crocidolite asbestos, and ultrafine carbon black in mice. Toxicol. Sci. 2011, 120, 123-135.
158. Haniu, H., Matsuda, Y., Takeuchi, K., Kim, Y. A. et al., Proteomics-based safety evaluation of multi-walled carbon nanotubes. Toxicol. Appl. Pharmacol. 2010, 242, 256-262.
159. Lin, Z. Q., Ma, L., X, Z. G., Zhang, H. S., Lin, B. C., A comparative study of lung toxicity in rats induced by three types of nanomaterials. Nanoscale Res. Lett. 2013, 8, 521. doi:10.1186/1556-276X-8-521.
160. Yuan, J., Gao, H., Ching, C. B., Comparative protein profile of human hepatoma HepG2 cells treated with graphene and single-walled carbon nanotubes: an iTRAQ-coupled 2D LC-MS/MS proteome analysis. Toxicol. Lett. 2011, 207, 213-221.
161. Triboulet, S., Aude-Garcia, C., Carriere, M., Diemer, H. et al., Molecular Responses of Mouse Macrophages to Copper and Copper Oxide Nanoparticles Inferred from Proteomic Analyses. Mol. Cell. Proteomics 2013, 12, 3108-3122.
162. Okoturo-Evans, O., Dybowska, A., Valsami-Jones, E., Cupitt, J., et al., Elucidation of Toxicity Pathways in Lung Epithelial Cells Induced by Silicon Dioxide Nanoparticles. Plos One 2013, 8, e72363.
163. Cha, M. H., Rhim, T., Kim, K. H., Jang, A. S. et al., Proteomic identification of macrophage migration-inhibitory factor upon exposure to TiO2 particles. Mol. Cell Proteomics 2007, 6, 56-63.
164. Ge, Y., Bruno, M., Wallace, K., Winnik, W., Prasad, R. Y., Proteome profiling reveals potential toxicity and detoxification pathways following exposure of BEAS-2B cells to engineered nanoparticle titanium dioxide. Proteomics 2011, 11, 2406-2422.
165. Jeon, Y. M., Park, S. K., Kim, W. J., Ham, J. H., Lee, M. Y., The effects of TiO2 nanoparticles on the protein expression in mouse lung. Mol. Cell. Toxicol. 2011, 7, 283-289.
166. Jeon, Y. M., Park, S. K., Rhee, S. K., Lee, M. Y., Proteomic profiling of the differentially expressed proteins by TiO2 nanoparticles in mouse kidney. Mol. Cell. Toxicol. 2010, 6, 419-425.
167. Triboulet, S., Aude-Garcia, C., Armand, L., Gerdil, A. et al., Analysis of cellular responses of macrophages to zinc ions and zinc oxide nanoparticles: a combined targeted and proteomic approach. Nanoscale 2014, 6, 6102-6114.
168. Karlsson, H., Lindbom, J., Ghafouri, B., Lindahl, M. et al., Wear particles from studded tires and granite pavement induce pro-inflammatory alterations in human monocyte-derived macrophages: a proteomic study. Chem. Res. Toxicol. 2011, 24, 45-53.
169. Rix, U., Superti-Furga, G., Target profiling of small molecules by chemical proteomics. Nat. Chem. Biol. 2009, 5, 616-624.
170. Bantscheff, M., Drewes, G., Chemoproteomic approaches to drug target identification and drug profiling. Bioorg. Med. Chem. 2012, 20, 1973-1978.
171. Colinge, J., Rix, U., Bennett, K. L., Superti-Furga, G., Systems biology analysis of protein-drug interactions. Proteomics Clin. Appl. 2012, 6, 102-116.
172. Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S. et al., Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 2007, 25, 1035-1044.
173. Rix, U., Hantschel, O., Durnberger, G., Remsing Rix, L. L. et al., Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood 2007, 110, 4055-4063.
174. Wang, J., Tan, X. F., Nguyen, V. S., Yang, P. et al., A quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasis. Mol. Cell. Proteomics 2014, 13, 876-886.
175. Rix, L. L. R., Rix, U., Colinge, J., Hantschel, O. et al., Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia 2009, 23, 477-485.
176. Duncan, J. S., Gyenis, L., Lenehan, J., Bretner, M. et al., An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets. Mol. Cell. Proteomics 2008, 7, 1077-1088.
177. Shi, H., Zhang, C. J., Chen, G. Y., Yao, S. Q., Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes. J. Am. Chem. Soc. 2012, 134, 3001-3014.
178. Colzani, M., Noberini, R., Romanenghi, M., Colella, G. et al., Quantitative chemical proteomics identifies novel targets of the anti-cancer multi-kinase inhibitor E-3810. Mol. Cell. Proteomics 2014, 13, 1495-1509.
179. Weber, C., Schreiber, T. B., Daub, H., Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells. J. Proteomics 2012, 75, 1343-1356.
180. Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A. et al., Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat. Biotechnol. 2011, 29, 255-265.
181. Rix, U., Rix, L. L. R., Terker, A. S., Fernbach, N. V. et al., A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells. Leukemia 2010, 24, 44-50.
182. Chen, C. Y., Yang, S. C., Lee, K. H., Yang, X. et al., The antitumor agent PBT-1 directly targets HSP90 and hnRNP A2/B1 and inhibits lung adenocarcinoma growth and metastasis. J. Med. Chem. 2014, 57, 677-685.
183. She, Y. M., Narindrasorasak, S., Yang, S., Spitale, N. et al., Identification of metal-binding proteins in human hepatoma lines by immobilized metal affinity chromatography and mass spectrometry. Mol. Cell. Proteomics 2003, 2, 1306-1318.
184. Smith, S. D., She, Y. M., Roberts, E. A., Sarkar, B., Using immobilized metal affinity chromatography, two-dimensional electrophoresis and mass spectrometry to identify hepatocellular proteins with copper-binding ability. J. Proteome Res. 2004, 3, 834-840.
185. Haystead, C. M., Gregory, P., Sturgill, T. W., Haystead, T. A., Gamma-phosphate-linked ATP-sepharose for the affinity purification of protein kinases. Rapid purification to homogeneity of skeletal muscle mitogen-activated protein kinase kinase. Eur. J. Biochem. 1993, 214, 459-467.
186. Ito, J., Heazlewood, J. L., Millar, A. H., Analysis of the soluble ATP-binding proteome of plant mitochondria identifies new proteins and nucleotide triphosphate interactions within the matrix. J. Proteome Res. 2006, 5, 3459-3469.
187. Lee, J. E., Park, J. H., Moon, P. G., Baek, M. C., Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome. Proteomics 2013, 13, 2998-3012.
188. Speers, A. E., Cravatt, B. F., Chemical strategies for activity-based proteomics. Chembiochem 2004, 5, 41-47.
189. Speers, A. E., Adam, G. C., Cravatt, B. F., Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition. J. Am. Chem. Soc. 2003, 125, 4686-4687.
190. Liu, Y., Patricelli, M. P., Cravatt, B. F., Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. USA 1999, 96, 14694-14699.
191. Jerina, D. M., Daly, J. W., Witkop, B., Zaltzman-Nirenberg, P., Udenfriend, S., The role of arene oxide-oxepin systems in the metabolism of aromatic substrates. 3. Formation of 1, 2-naphthalene oxide from naphthalene by liver microsomes. J. Am. Chem. Soc. 1968, 90, 6525-6527.
192. Brodie, B. B., Reid, W. D., Cho, A. K., Sipes, G. et al., Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc. Natl. Acad. Sci. USA 1971, 68, 160-164.
193. Grover, P. L., Sims, P., Huberman, E., Marquardt, H. et al., In vitro transformation of rodent cells by K-region derivatives of polycyclic hydrocarbons. Proc. Natl. Acad. Sci. USA 1971, 68, 1098-1101.
194. Mitchell, J. R., Snodgrass, W. R., Gillette, J. R., The role of biotransformation in chemical-induced liver injury. Environ.Health Perspect. 1976, 15, 27-38.
195. Anderson, N. L., Copple, D. C., Bendele, R. A., Probst, G. S., Richardson, F. C., Covalent protein modifications and gene expression changes in rodent liver following administration of methapyrilene: a study using two-dimensional electrophoresis. Fundam. Appl. Toxicol. 1992, 18, 570-580.
196. Richardson, F. C., Strom, S. C., Copple, D. M., Bendele, R. A. et al., Comparisons of protein-changes in human and rodent hepatocytes induced by the rat-specific carcinogen, methapyrilene. Electrophoresis 1993, 14, 157-161.
197. Martyniuk, C. J., Feswick, A., Fang, B., Koomen, J. M. et al., Protein targets of acrylamide adduct formation in cultured rat dopaminergic cells. Toxicol. Lett. 2013, 219, 279-287.
198. Ariza, A., Garzon, D., Abanades, D. R., de los Rios, V. et al., Protein haptenation by amoxicillin: high resolution mass spectrometry analysis and identification of target proteins in serum. J. Proteomics 2012, 77, 504-520.
199. Asif, A. R., Armstrong, V. W., Voland, A., Wieland, E. et al., Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats. Biochimie 2007, 89, 393-402.
200. Luo, J., Hill, B. G., Gu, Y., Cai, J. et al., Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H3673-H3684.
201. Koen, Y. M., Gogichaeva, N. V., Alterman, M. A., Hanzlik, R. P., A proteomic analysis of bromobenzene reactive metabolite targets in rat liver cytosol in vivo. Chem. Res. Toxicol. 2007, 20, 511-519.
202. Koen, Y. M., Hajovsky, H., Liu, K., Williams, T. D. et al., Liver protein targets of hepatotoxic 4-bromophenol metabolites. Chem. Res. Toxicol. 2012, 25, 1777-1786.
203. Van Laar, V. S., Mishizen, A. J., Cascio, M., Hastings, T. G., Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiol. Dis. 2009, 34, 487-500.
204. Moro, S., Chipman, J. K., Antczak, P., Turan, N. et al., Identification and pathway mapping of furan target proteins reveal mitochondrial energy production and redox regulation as critical targets of furan toxicity. Toxicol. Sci. 2012, 126, 336-352.
205. Lame, M. W., Jones, A. D., Wilson, D. W., Segall, H. J., Monocrotaline pyrrole targets proteins with and without cysteine residues in the cytosol and membranes of human pulmonary artery endothelial cells. Proteomics 2005, 5, 4398-4413.
206. Isbell, M. A., Morin, D., Boland, B., Buckpitt, A. et al., Identification of proteins adducted by reactive naphthalene metabolites in vitro. Proteomics 2005, 5, 4197-4204.
207. Lame, M. W., Jones, A. D., Wilson, D. W., Segall, H. J., Protein targets of 1, 4-benzoquinone and 1, 4-naphthoquinone in human bronchial epithelial cells. Proteomics 2003, 3, 479-495.
208. Koen, Y. M., Sarma, D., Hajovsky, H., Galeva, N. A. et al., Protein targets of thioacetamide metabolites in rat hepatocytes. Chem. Res. Toxicol. 2013, 26, 564-574.
209. Ikehata, K., Duzhak, T. G., Galeva, N. A., Ji, T. et al., Protein targets of reactive metabolites of thiobenzamide in rat liver in vivo. Chem. Res. Toxicol. 2008, 21, 1432-1442.
210. Campostrini, N., Areces, L. B., Rappsilber, J., Pietrogrande, M. C. et al., Spot overlapping in two-dimensional maps: a serious problem ignored for much too long. Proteomics 2005, 5, 2385-2395.
211. Hunsucker, S. W., Duncan, M. W., Is protein overlap in two-dimensional gels a serious practical problem? Proteomics 2006, 6, 1374-1375.
212. Colignon, B., Raes, M., Dieu, M., Delaive, E., Mauro, S., Evaluation of three-dimensional gel electrophoresis to improve quantitative profiling of complex proteomes. Proteomics 2013, 13, 2077-2082.
213. Hoving, S., Voshol, H., van Oostrum, J., Towards high performance two-dimensional gel electrophoresis using ultrazoom gels. Electrophoresis 2000, 21, 2617-2621.
214. Westbrook, J. A., Yan, J. X., Wait, R., Welson, S. Y., Dunn, M. J., Zooming-in on the proteome: very narrow-range immobilised pH gradients reveal more protein species and isoforms. Electrophoresis 2001, 22, 2865-2871.
215. Zhang, Y., Dayalan Naidu, S., Samarasinghe, K., Van Hecke, G. C. et al., Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation. Br. J. Cancer 2014, 110, 71-82.
216. Peng, L., Turesky, R. J., Optimizing proteolytic digestion conditions for the analysis of serum albumin adducts of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine, a potential human carcinogen formed in cooked meat. J. Proteomics 2014, 103, 267-278.
217. Fan, X. Z., Wang, J. L., Soman, K. V., Ansari, G. A. S., Khan, M. F., Aniline-induced nitrosative stress in rat spleen: proteomic identification of nitrated proteins. Toxicol. Appl. Pharmacol. 2011, 255, 103-112.
218. Bruno, M., Moore, T., Nesnow, S., Ge, Y., Protein carbonyl formation in response to propiconazole-induced oxidative stress. J. Proteome Res. 2009, 8, 2070-2078.
219. Steiner, S. R., Milton, E., Philbert, M. A., A comparative study of protein carbonylation and mitochondrial dysfunction using the neurotoxicants 1, 3-dinitrobenzene, 3-nitropropionic acid, and 3-chloropropanediol. Neurotoxicology 2013, 37, 74-84.
220. Merkley, M. A., Hildebrandt, E., Podolsky, R. H., Arnouk, H. et al., Large-scale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 E6 and E7 oncogenes. Proteome Sci 2009, 7, 29. doi:10.1186/1477-5956-7-29.
221. Maes, E., Landuyt, B., Mertens, I., Schoofs, L., Interindividual variation in the proteome of human peripheral blood mononuclear cells. PLoS One 2013, 8, e61933.
222. Winkler, W., Zellner, M., Diestinger, M., Babeluk, R. et al., Biological variation of the platelet proteome in the elderly population and its implication for biomarker research. Mol. Cell. Proteomics 2008, 7, 193-203.
223. Gautier, V., Mouton-Barbosa, E., Bouyssie, D., Delcourt, N. et al., Label-free quantification and shotgun analysis of complex proteomes by one-dimensional SDS-PAGE/NanoLC-MS: evaluation for the large scale analysis of inflammatory human endothelial cells. Mol. Cell. Proteomics 2012, 11, 527-539.
224. Wang, H., Alvarez, S., Hicks, L. M., Comprehensive comparison of iTRAQ and label-free LC-based quantitative proteomics approaches using two Chlamydomonas reinhardtii strains of interest for biofuels engineering. J. Proteome Res. 2012, 11, 487-501.
225. Uitto, P. M., Lance, B. K., Wood, G. R., Sherman, J. et al., Comparing SILAC and two-dimensional gel electrophoresis image analysis for profiling urokinase plasminogen activator signaling in ovarian cancer cells. J. Proteome Res. 2007, 6, 2105-2112.
226. Antberg, L., Cifani, P., Sandin, M., Levander, F., James, P., Critical comparison of multidimensional separation methods for increasing protein expression coverage. J. Proteome Res. 2011, 11, 2644-2652.
227. Karp, N. A., Huber, W., Sadowski, P. G., Charles, P. D. et al., Addressing accuracy and precision issues in iTRAQ quantitation. Mol. Cell. Proteomics 2010, 9, 1885-1897.
228. Stessl, M., Noe, C. R., Lachmann, B., Influence of image-analysis software on quantitation of two-dimensional gel electrophoresis data. Electrophoresis 2009, 30, 325-328.
229. Aicher, L., Meier, G., Norcross, A. J., Jakubowski, J. et al., Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization. Biochem. Pharmacol. 1997, 53, 723-731.
230. Becker, M., De Bastiani, M. A., Muller, C. B., Markoski, M. M. et al., High cofilin-1 levels correlate with cisplatin resistance in lung adenocarcinomas. Tumor Biol. 2014, 35, 1233-1238.
231. Jeong, C. Y., Hah, Y. S., Choi, B. I., Lee, S. M. et al., Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma. Oncol. Rep. 2012, 28, 1283-1292.
232. Petrak, J., Ivanek, R., Toman, O., Cmejla, R. et al., Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 2008, 8, 1744-1749.
233. Ding, X., Kaminsky, L. S., Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol.Toxicol. 2003, 43, 149-173.
234. Diz, A. P., Carvajal-Rodriguez, A., Skibinski, D. O., Multiple hypothesis testing in proteomics: a strategy for experimental work. Mol. Cell. Proteomics 2011, 10, M110.004374.
235. Li, A. P., Biomarkers and human hepatocytes. Biomark. Med. 2014, 8, 173-183.
236. Pal, A., Copper toxicity induced hepatocerebral and neurodegenerative diseases: an urgent need for prognostic biomarkers. Neurotoxicology 2014, 40, 97-101.
237. Collins, B. C., Miller, C. A., Sposny, A., Hewitt, P. et al., Development of a pharmaceutical hepatotoxicity biomarker panel using a discovery to targeted proteomics approach. Mol. Cell. Proteomics 2012, 11, 394-410.